With a coronavirus vaccine still numerous months off, business are hurrying to evaluate what might be the next best thing: antibody drugs that fight the infection right now, without having to train the immune system to do the job. (Aug. 12)
AP
With a coronavirus vaccine still numerous months off, business are hurrying to evaluate what might be the next best thing: antibody drugs that fight the infection right now, without having to train the immune system to do the job. (Aug. 12)
AP
Comments
Post a Comment